Virtu KCG Holdings’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $291K | Buy |
7,851
+6,445
| +458% | +$239K | 0.01% | 1697 |
|
|
2017
Q1 | $76K | Sell |
1,406
-8,042
| -85% | -$435K | ﹤0.01% | 2733 |
|
|
2016
Q4 | $502K | Buy |
+9,448
| New | +$502K | 0.01% | 1468 |
|
|
2016
Q3 | – | Sell |
-3,620
| Closed | -$238K | – | 3080 |
|
|
2016
Q2 | $238K | Buy |
3,620
+1,841
| +103% | +$121K | ﹤0.01% | 2122 |
|
|
2016
Q1 | $101K | Sell |
1,779
-225
| -11% | -$12.8K | ﹤0.01% | 2320 |
|
|
2015
Q4 | $471K | Sell |
2,004
-1,184
| -37% | -$278K | 0.01% | 1271 |
|
|
2015
Q3 | $504K | Buy |
3,188
+1,809
| +131% | +$286K | 0.01% | 1204 |
|
|
2015
Q2 | $522K | Buy |
1,379
+595
| +76% | +$225K | 0.01% | 1130 |
|
|
2015
Q1 | $328K | Sell |
784
-952
| -55% | -$398K | 0.01% | 1423 |
|
|
2014
Q4 | $475K | Sell |
1,736
-377
| -18% | -$103K | 0.01% | 1159 |
|
|
2014
Q3 | $411K | Buy |
2,113
+1,309
| +163% | +$255K | 0.01% | 1307 |
|
|
2014
Q2 | $196K | Sell |
804
-681
| -46% | -$166K | ﹤0.01% | 2113 |
|
|
2014
Q1 | $394K | Buy |
+1,485
| New | +$394K | ﹤0.01% | 1236 |
|
|
2013
Q4 | – | Sell |
-2,860
| Closed | -$1.52M | – | 2584 |
|
|
2013
Q3 | $1.52M | Buy |
+2,860
| New | +$1.52M | 0.02% | 427 |
|